Product Description: Anticancer agent 270 (Compound 8e) is an inhibitor that acts on tubulin. Its IC50 value against MCF-7 breast cancer cells is 1.02 μM. Through a dual mechanism of action, namely inducing Apoptosis and destabilizing microtubules, it exerts significant anti-proliferative activity against breast cancer cells. Anticancer agent 270 can be applied to research in the field of cancer[1].
Formula: C23H21N3O6S
References: [1]Saadh M J, et al. Design and synthesis of chromene-triazole hybrids via recyclable magnetic nanocatalyst: Potent dual-acting anticancer agents targeting apoptotic and microtubule dynamics[J]. Journal of Molecular Structure, 2025, 1338: 142093.
Molecular Weight: 467.49
Research Area: Cancer
Target: Microtubule/Tubulin